The AAV encoding Pcsk9 D377Y (Asp374-to-Tyr mutant) targets hepatocytes by inducing hepatic low-density lipoprotein receptor degradation15, which was used to induce hyperlipidemia and combined with AngII infusion and a Western-type diet to induce AAA. Here, VLDLR is linked to hyperlipidemia.